Trial Profile
Clinical Trials Insight: 700023279
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 May 2007
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Nautilus Biotech
- 18 May 2007 New trial record.